Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615774-16-004771
Filing Date
2016-04-01
Accepted
2016-04-01 16:54:31
Documents
2
Period of Report
2016-05-06
Effectiveness Date
2016-04-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A s102878_def14a.htm DEF 14A 452927
2 GRAPHIC tlogo.jpg GRAPHIC 19697
  Complete submission text file 0001615774-16-004771.txt   481364
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37606 | Film No.: 161547877
SIC: 8731 Services-Commercial Physical & Biological Research